- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06654427
Trauma-Informed Obstetric Care: Development and Implementation of a Toolkit for Obstetrics (OBTIC) (OBTIC)
Trauma-Informed Obstetric Care: Development and Implementation of a Stakeholder- Informed Toolkit for Obstetric Providers and Patients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The goal of this study is to develop a stakeholder-informed toolkit for obstetric providers and patients to support the implementation of trauma-informed care (TIC) in routine clinical practice. Following interviews with providers and pregnant/postpartum participants as well as convening with a community working group of stakeholders, an OBTIC toolkit blueprint will be drafted for testing.
In the pilot implementation phase, all clinicians and administrators at an outpatient obstetrics clinic will participate in the OBTIC intervention. However, only providers who consent to participate in surveys and interviews will be contacted by the PI to complete surveys (assessment of attitudes related to TIC and usefulness of toolkit components) at the mid-point (month 2) and after completion of the pilot (month 4). Clinicians will also be interviewed as a group (physicians and nurses separately) following a staff meeting; interviews will assess perceived acceptability, feasibility, appropriateness and helpfulness of the toolkit. Additionally, 12-20 postpartum participants, who were treated at the clinic during the pilot, will be recruited for brief semi-structured qualitative interviews and surveys following the completion of the pilot. In order to assess adoption of the trauma screening component of the TIC toolkit, I will conduct chart review of initial prenatal visits at baseline (3 months prior) during (9 months of the pilot trial) and after completion (3 months following completion) of the pilot trial to assess rates of screening. To assess exploratory efficacy outcomes, I will use chart review to collect data on 1) Perinatal care: care engagement (appointment adherence, attendance of postpartum follow-up), and care choices (elective augmentation of delivery); 2) Maternal-infant outcomes: breastfeeding (initiation and continuation), infant birthweight, and post-partum pain; 3) Perinatal mental health: depression (EPDS or PHQ-9), and anxiety (GAD-7). In the sample of patients who elect to participate in interviews, I will also assess prior trauma exposure (ACE and BTQ), PTSD symptoms (PCL-5 and City Birth Trauma Scale) and experiences of discrimination and safety in care (Personal Discrimination Multi-Item Measure).
Sample sizes for the qualitative components of the study were determined in order to achieve adequate distribution to stratify by key study variables (trauma exposure, pregnancy status, provider type). For the pilot implementation trial, the aim of the quantitative aims is to generate data needed to evaluate the feasibility and acceptability of the designed intervention, and to generate estimates of key parameters (variance of outcome measures) to approach power and sample size estimation for an efficacy study.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02903
- The Miriam Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion criteria for pregnant and postpartum patients for individual interviews:
- ≥ 18 years old
- under the care of an obstetrician or nurse practitioner in the U.S.,
- English-speaking
- have had ≥2 prenatal care encounters, and postpartum if they delivered a surviving infant within the past 12 months
- received care at either of the pilot sites during the pilot trial.
Pregnant and postpartum participants will be eligible for the trauma-exposed group if they
- report a history of trauma in childhood or adulthood,
- are ≥1 year from the time of the traumatic experience
- are not currently at-risk for harm from self or others
- are willing to discuss experiences related to trauma and are able to do so without experiencing undue distress.
- Patient participants will be eligible for the non-trauma group if they deny trauma.
Inclusion criteria for provider participants:
- Practicing physicians or nurses
- ≥ 6 months of experience in obstetrics
- English speaking
- Clinician Participants (providers in the participating clinics) will be enrolled in the pilot trial of the obstetric trauma-informed care toolkit intervention.
- Clinician participants will be enrolled for group or individual interviews if they consent to do so and meet above criteria.
Exclusion Criteria:
Patient participants will be excluded from the study interviews if they report
- a current unsafe environment (determined by the Assessment of Immediate Safety)
- report suicidal ideation (as determined by the PHQ9)
- report difficulty discussing experiences related to trauma.
Provider participants will be excluded from the study if they do not work at one of the pilot clinics. Provider participants will be excluded from the study interviews if they do not consent to be interviewed.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Implementation of OBTIC
The OB-TIC intervention toolkit will be pilot tested in outpatient obstetrics clinics.
OB-TIC will be implemented for 9 months during which time I will assess providers' and patients' perceptions of acceptability, appropriateness, and feasibility of OB-TIC.
Adoption of OB-TIC, attitudes towards TIC, appointment adherence and care choices, maternal-infant health outcomes, and patient mental health will be assessed before, during, and after the pilot.
|
The OB-TIC toolkit will include provider and staff training on trauma- informed care and information on trauma-related perinatal concerns; trauma assessment tools; trauma-informed procedure modifications; clinical language guides; patient-facing resources including birth strategies, referral resources, and education; and clinical language.
The OB-TIC intervention will utilize the toolkit to integrate trauma-informed care into clinical practice.
Implementation strategies will be assessed to determine the most effective method for integrating OB-TIC content into practice.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of intervention components for adaptation and scale-up implementation
Time Frame: Surveys to evaluate specific components of the OB-TIC toolkit will be given in early implementation (2-3 months)
|
Once the OB-TIC toolkit is complete, I will work with my mentorship team to create a survey to assess the most frequently used components of the toolkit.
For example, if OB-TIC includes trauma-informed birth strategies, mental health referrals, and a modified exam procedure checklist, the survey would list each of these components and ask clinicians how often each component was used, rate how useful the component was, and whether they made changes to any of the materials.
|
Surveys to evaluate specific components of the OB-TIC toolkit will be given in early implementation (2-3 months)
|
|
Evaluation of intervention components for adaptation and scale-up implementation
Time Frame: Surveys to evaluate specific components of the OB-TIC toolkit will be given in sustainment (6-12 months)
|
Once the OB-TIC toolkit is complete, I will work with my mentorship team to create a survey to assess the most frequently used components of the toolkit.
For example, if OB-TIC includes trauma-informed birth strategies, mental health referrals, and a modified exam procedure checklist, the survey would list each of these components and ask clinicians how often each component was used, rate how useful the component was, and whether they made changes to any of the materials.
|
Surveys to evaluate specific components of the OB-TIC toolkit will be given in sustainment (6-12 months)
|
|
Change in Acceptability of Intervention Measure
Time Frame: Clinicians are given the survey in early implementation (2-3 months) and sustainment (6-12 months)
|
Clinicians will rate acceptability on a 5-point ordinal scale ranging from "completely disagree" to "completely agree".
The measure consists of 4 items and has a test-retest reliability Cronbach alpha of .83.
|
Clinicians are given the survey in early implementation (2-3 months) and sustainment (6-12 months)
|
|
Change in Intervention Appropriateness Measure
Time Frame: Clinicians are given the survey in early implementation (2-3 months) and sustainment (6-12 months)
|
Clinicians will rate appropriateness on a 5-point ordinal scale ranging from "completely disagree" to "completely agree".
The measure consists of 4 items and has a test-retest reliability Cronbach alpha of .87.
|
Clinicians are given the survey in early implementation (2-3 months) and sustainment (6-12 months)
|
|
Change in Feasibility of Intervention Measure
Time Frame: Clinicians are given the survey in early implementation (2-3 months) and sustainment (6-12 months)
|
Clinicians will rate feasibility on a 5-point ordinal scale ranging from "completely disagree" to "completely agree".
The measure consists of 4 items and has a test-retest reliability Cronbach alpha of .88.
|
Clinicians are given the survey in early implementation (2-3 months) and sustainment (6-12 months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Patient health questionnaire (PHQ-9)
Time Frame: The PHQ9 will be used to assess patient mood changes before (3 months prior) during (9 months) and 3 months after the pilot trial via chart review
|
The PHQ-9 is a standardized measure of depression which has been used widely in obstetric settings.
It consists of 9 questions and is scored from 0 to 3. Clinical significance is determined by a score of 5 or higher for mild depression and 10 or higher for moderate depression.
The PHQ9 has an internal consistency of .89.
|
The PHQ9 will be used to assess patient mood changes before (3 months prior) during (9 months) and 3 months after the pilot trial via chart review
|
|
City Birth Trauma Scale
Time Frame: 9-12 months post-intervention
|
The City Birth Trauma Scale is a 29 item scale that assesses perinatal experiences according to DSM 5 PTSD criteria.
It has been shown to have reliability of .92.
|
9-12 months post-intervention
|
|
Change in Appointment Adherence
Time Frame: Chart review will be used to assess the change in ratio of attended to scheduled appointments before (3 months prior) during (for 9 months of implementation) and after (3 months following the 9 month implementation period) the pilot trial.
|
Appointment Adherence will be measured by assessing the ratio of attended to scheduled appointments.
The type of appointment will also be recorded (ultrasound, initial obstetric visit, pelvic exam, medication consultation, glucose testing, etc)
|
Chart review will be used to assess the change in ratio of attended to scheduled appointments before (3 months prior) during (for 9 months of implementation) and after (3 months following the 9 month implementation period) the pilot trial.
|
|
Change in Elective augmentation of delivery
Time Frame: 3 months before the pilot, during the 9 months of implementation, and 3 months after the pilot trial assessed via chart review
|
Patient preferences for augmentation of delivery will be recorded via chart review and dichotomized as yes or no.
|
3 months before the pilot, during the 9 months of implementation, and 3 months after the pilot trial assessed via chart review
|
|
Change Breastfeeding frequency
Time Frame: 3 months before the pilot, during the 9 months of implementation, and 3 months after the pilot trial assessed via chart review
|
Initiation and length of continuation of breastfeeding up to 6 weeks as noted at postpartum follow-up appointment.
|
3 months before the pilot, during the 9 months of implementation, and 3 months after the pilot trial assessed via chart review
|
|
Change in average infant birth-weight
Time Frame: 3 months before the pilot, during the 9 months of implementation, and 3 months after the pilot trial assessed via chart review
|
Infant birthweight as recorded in delivery note in medical record.
|
3 months before the pilot, during the 9 months of implementation, and 3 months after the pilot trial assessed via chart review
|
|
Change in Post-partum pain ratings
Time Frame: 3 months before the pilot, during the 9 months of implementation, and 3 months after the pilot trial assessed via chart review
|
Postpartum pain as recorded in postpartum note in medical record.
|
3 months before the pilot, during the 9 months of implementation, and 3 months after the pilot trial assessed via chart review
|
|
Change in Generalized Anxiety Disorder Assessment (GAD-7)
Time Frame: 3 months before the pilot, during the 9 months of implementation, and 3 months after the pilot trial assessed via chart review
|
The GAD-7 is a self-report measure of anxiety and worry with higher scores indicating greater severity in symptoms.
The GAD-7 has demonstrated excellent internal consistency and reliability (.92).
|
3 months before the pilot, during the 9 months of implementation, and 3 months after the pilot trial assessed via chart review
|
|
Posttraumatic stress disorder checklist for DSM-5 (PCL-5)
Time Frame: After completion of the pilot trial (9-12 months after the start of implementation), a subset of patients will be recruited for interviews and completion of surveys
|
The PCL-5 is a 20 item self-report measure assessing 20 post-traumatic stress disorder symptoms according to criteria in the Diagnostic and Statistical Manual (DSM-5).
It has demonstrated good internal consistency and reliability (.94).
A total severity score is calculated from the sum of the responses to the 20 items.
|
After completion of the pilot trial (9-12 months after the start of implementation), a subset of patients will be recruited for interviews and completion of surveys
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Laura G Ward, Ph.D., The Miriam Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- K23HD107296-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Trauma
-
Humacyte, Inc.CompletedTrauma | Trauma Injury | Trauma, Multiple | Trauma BluntUkraine
-
University Hospital, AngersRecruiting
-
Arrowhead Regional Medical CenterCompletedTrauma Injury | Trauma Blunt | Vascular TraumaUnited States
-
Prof. Dr. Cemil Tascıoglu Education and Research...CompletedTrauma Injury | Trauma, MultipleTurkey
-
Wonju Severance Christian HospitalNational Research Foundation of KoreaCompletedTrauma Injury | Trauma, MultipleKorea, Republic of
-
Rabin Medical CenterIsraeli Ministry of SecurityUnknown
-
Hospital Departamental de VillavicencioCooperative University of Colombia; Clínica PrimaveraRecruitingTrauma Injury | Trauma Patients in ICU | Trauma (Including Fractures) | Trauma Patients | Trauma ICU PatientsColombia
-
Oslo University HospitalUniversity of Oslo; Sunnaas Rehabilitation Hospital; South-Eastern Norway Regional...RecruitingTrauma Injury | Trauma, Multiple | PolytraumaNorway
-
Chang, Steve S., M.D.Santa Barbara Cottage Hospital; Accumetrics, Inc.CompletedHead Injury Trauma BluntUnited States
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker Cochin; Francophone Pediatric Resuscitation...Completed
Clinical Trials on Obstetric Trauma Informed Care Toolkit
-
Columbia UniversityHospital Materno Infantil Ramón SardáRecruitingTrauma | Breast Feeding | Mother to Child TransmissionArgentina
-
Johns Hopkins Bloomberg School of Public HealthCompletedHIV Infections | Domestic ViolenceUnited States
-
Brigham and Women's HospitalEnrolling by invitationTrauma and Stressor Related Disorders | Violence, Domestic | Violence, Sexual | Violence, StructuralUnited States
-
University of MinnesotaNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
University of LethbridgeCompletedStress, Psychological | Mental Health Wellness 1 | Eating Behavior | Eating HabitCanada
-
University of LethbridgeCompletedCovid19 | Stress, Psychological | Addiction | Mental Health Wellness 1Canada
-
Yale UniversityPatient-Centered Outcomes Research InstituteCompletedSexual AbuseUnited States
-
Mersin UniversityCompletedPsychological Well-being | Childbirth | Care Pattern, MaternalTurkey
-
Veterans Medical Research FoundationUnited States Department of Defense; Brown University; Seattle Institute for... and other collaboratorsCompletedPost-traumatic Stress Disorders | Guilt | ShameUnited States
-
Vanderbilt UniversityCompleted